Advancing Precision Oncology with New Tumor Organoids

Patient-derived tumor organoids are emerging as high-fidelity preclinical models for precision oncology, offering a way to test cancer treatments on three-dimensional cell clusters that mirror a patient’s specific disease. Recent research led by investigators at Weill Cornell Medicine demonstrates that these “avatars” can reliably predict treatment sensitivity, potentially expanding the pool of patients eligible for … Read more

Tau Buildup in PSP Disrupts Brain Networks and Cognitive Function

Progressive supranuclear palsy (PSP) symptoms, including cognitive decline, may stem from remote brain network disruptions rather than just local tau protein accumulation. Research published in Science Advances by the National Institutes for Quantum Science and Technology (QST) indicates that tau deposits in deep brain regions can impair distant cortical areas, such as the prefrontal cortex, … Read more

New Therapy Harnesses Cells’ Waste Removal to Target Multiple Myeloma

Researchers at VCU Massey Comprehensive Cancer Center have developed an experimental molecule called an autophagy-targeting chimera (AUTAC) that dismantles the MCL1 survival protein to kill multiple myeloma cells. According to a study published in Cell Death & Disease, this targeted protein degrader works with existing proteasome inhibitors to reduce cancer cell viability by 50% within … Read more

BCG Vaccine May Alter Human Brain Immunity

The Bacillus Calmette-Guérin (BCG) vaccine, typically used to prevent tuberculosis, may remodel the brain’s immune environment to potentially lower Alzheimer’s disease risk, according to research published in Communications Medicine. A year-long study led by Mass General Brigham investigators found the vaccine increased immune cell responsiveness and altered Alzheimer’s-related biomarkers in older adults without pre-existing pathology. … Read more

New Experimental Drug Protects Nerve Cells From ALS Damage

University of Arizona researchers have developed an experimental drug, XL20, that shows potential to protect nerve cells from damage associated with amyotrophic lateral sclerosis (ALS). According to a study published in Nature Aging, the drug targets a specific region of the TDP-43 protein to prevent toxic clumping, a process that contributes to neurodegeneration in ALS … Read more

How Obesity Drives Invasive Breast Cancer: Key Molecular Pathways

Obesity is associated with a distinct molecular program in breast tissue that drives the transition from premalignant lesions to invasive cancer, according to a study published in The American Journal of Pathology. Researchers found that tumors in obese patients rely on stress-adaptive pathways and microenvironment remodeling rather than classical invasive pathways, suggesting that metabolic health … Read more

How Psychological Traits Influence Alzheimer’s Biology

Long-standing psychological traits, including neuroticism and a lack of purpose, track distinct molecular pathways in Alzheimer’s dementia, according to a multi-omics study published in Translational Psychiatry. Researchers from the Religious Orders Study (ROS) and the Rush Memory and Aging Project (MAP) found that while traditional pathology and genetic risk factors identify overall disease susceptibility, these … Read more

Does Glucosamine Worsen Alzheimer’s? The Link to Brain Glycosylation

Glucosamine, a widely consumed supplement for joint health, may exacerbate cognitive decline in individuals already diagnosed with dementia, according to a study published in Nature Metabolism. Researchers at the University of Florida found that the supplement increased brain protein glycosylation in mouse models, leading to worsened memory deficits. In a retrospective analysis of human health … Read more

IV Statins Reduce Heart Attack Muscle Damage

Intravenous administration of atorvastatin during an active heart attack significantly reduces cardiac tissue damage compared to oral loading doses, according to a study published in the European Heart Journal. Researchers at the Institut de Recerca Sant Pau (IR Sant Pau) found this method limits necrosis and inflammation by acting during the critical window of ischemic … Read more

New Hybrid Lens Design Slashes 3D Microscopy Costs

Columbia University researchers have developed a new optical framework, HySIL (Hybrid Solid–Liquid Optics), that enables high-resolution 3D tissue imaging at a fraction of the cost and complexity of traditional systems. By using immersion liquid as an active optical component, the design allows affordable air-based microscope lenses to capture deep-tissue images, according to a study published … Read more